ALNYLAM PHARMACEUTICALS, INC. ($ALNY)
Filing Information
| Accession Number | 0001735276-26-000011 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 14, 2026 |
| Document Date | Jan 11, 2026 |
| Document | View SEC Filing |
Transactions
28
Total Shares
7,600
Total Value
$1,395,992.00
P&L
+inf% (+$1,186,246.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CSO & EVP, Head of Research | Common Stock | โ | Jan 11, 2026 | Grant/Award | 3,800 | $0.00 | $0.00 | 25,064 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 12, 2026 | Sale | 39 | $353.95 | $13,804.05 | 25,025 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 12, 2026 | Sale | 42 | $355.16 | $14,916.72 | 24,983 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 12, 2026 | Sale | 41 | $356.09 | $14,599.69 | 24,942 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 12, 2026 | Sale | 96 | $357.17 | $34,288.32 | 24,846 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 12, 2026 | Sale | 123 | $358.18 | $44,056.14 | 24,723 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 12, 2026 | Sale | 85 | $359.14 | $30,526.90 | 24,638 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 12, 2026 | Sale | 155 | $360.22 | $55,834.10 | 24,483 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 12, 2026 | Sale | 98 | $361.45 | $35,422.10 | 24,385 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 12, 2026 | Sale | 73 | $362.38 | $26,453.74 | 24,312 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 12, 2026 | Sale | 47 | $363.55 | $17,086.85 | 24,265 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 12, 2026 | Sale | 199 | $364.83 | $72,601.17 | 24,066 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 12, 2026 | Sale | 220 | $365.56 | $80,423.20 | 23,846 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 12, 2026 | Sale | 50 | $366.41 | $18,320.50 | 23,796 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 12, 2026 | Sale | 41 | $367.40 | $15,063.40 | 23,755 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 12, 2026 | Sale | 92 | $368.62 | $33,913.04 | 23,663 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 12, 2026 | Sale | 40 | $369.48 | $14,779.20 | 23,623 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 12, 2026 | Sale | 19 | $370.87 | $7,046.53 | 23,604 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 12, 2026 | Sale | 2 | $372.46 | $744.92 | 23,602 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 12, 2026 | Sale | 14 | $374.44 | $5,242.16 | 23,588 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 12, 2026 | Sale | 19 | $375.65 | $7,137.35 | 23,569 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 12, 2026 | Sale | 15 | $377.82 | $5,667.30 | 23,554 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 13, 2026 | Sale | 197 | $367.52 | $72,401.44 | 23,357 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 13, 2026 | Sale | 562 | $368.76 | $207,243.12 | 22,795 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 13, 2026 | Sale | 644 | $370.00 | $238,280.00 | 22,151 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 13, 2026 | Sale | 485 | $371.24 | $180,051.40 | 21,666 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 13, 2026 | Sale | 280 | $372.93 | $104,420.40 | 21,386 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Jan 13, 2026 | Sale | 122 | $374.33 | $45,668.26 | 21,264 | Direct | โ | View Details |